Your search for comorbidities returned 56 results

Long-chain acylcarnitine metabolites (factors 5 and 7) were associated with an increased risk of all-cause mortality or hospitalization.

Pulmonary embolism risk after cerebral venous thromboembolism is significantly lower than after deep vein thromboembolism.

In an observational study of the ADAPT-DES trial, high platelet reactivity was associated with adverse ischemic events in patients undergoing percutaneous coronary intervention.

This simple scoring system stratified risk at 30 days and 1 year into low-risk, moderate-risk, and high-risk categories.

Patients with acute coronary syndrome had significantly higher odds of committing suicide compared with healthy individuals.

Previously abandoned leads were associated with more complications from infection.

Native coronary artery PCI produced better outcomes in patients with previous CABG.

Adjusted hazard ratios for mortality suggested similar outcomes in carotid artery stenting and carotid endarterectomy.

Researchers analyzed the relationship between chronotropic incompetence and exercise capacity in patients with chronic heart failure.

Two studies presented at CHEST 2016 revealed that rivaroxaban lowered the risk of venous thromboembolism without increasing risk of major bleeding.